The crosstalk between MSCs and tumor cells also involves the activation of pro-inflammatory and survival-signaling pathways, such as the NFκB, PI3K/Akt, Wnt, MAPK, and JAK/STAT signaling pathways that mediate tumor progression, metastasis formation, and angiogenesis [120,167,168]. This evidence concerns the gene AKT1 and neoplasm.